Microbiota and Colorectal Cancer: ISM is honoured to welcome Pr Iradj Sobhani as distinguished speaker
As Editor-in-Chief of the Journal of the International Society of Microbiota, Pr Iradj Sobhani was invited by the scientific committee to give a strategic presentation about "Anti cancer chemotherapy and Microbiota changes in Colorectal cancer" during the 4th World Congress on Targeting Microbiota to be held at Institut Pasteur on October 17-19, 2016.
According Pr Sobhani: "A colon cancer related dysbiosis has been reported and specific bacteria from either stool Microbiota or gut Microbiota have been characterized. Whether human microbiome might impact response of tumour to therapies is now a crucial issue. Several preliminary studies conducted in animals as well as in human support this hypothesis. W’ll summarize these data and give an overview on our preliminary pilot study under Folfox therapy."
For more information about the congress: www.microbiota-site.com
Marvin Edeas - Chairman of the scientific committee
